Jag Capital Management Has Trimmed By $6.99 Million Its Applied Materials (AMAT) Holding; 7 Bullish Analysts Covering Seattle Genetics, Inc. (SGEN)

December 7, 2017 - By Migdalia James

Among 18 analysts covering Seattle Genetics (NASDAQ:SGEN), 7 have Buy rating, 0 Sell and 11 Hold. Therefore 39% are positive. Seattle Genetics had 56 analyst reports since July 31, 2015 according to SRatingsIntel.

Needham maintained Seattle Genetics, Inc. (NASDAQ:SGEN) rating on Monday, October 23. Needham has “Buy” rating and $72.0 target. The rating was maintained by Jefferies with “Buy” on Tuesday, September 12. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) has “Hold” rating given on Monday, June 26 by Cantor Fitzgerald. The stock has “Hold” rating by Oppenheimer on Monday, June 26. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) earned “Buy” rating by H.C. Wainwright on Friday, October 27. The firm has “Hold” rating given on Wednesday, August 16 by Oppenheimer. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) earned “Overweight” rating by Barclays Capital on Thursday, February 4. The firm has “Sell” rating given on Wednesday, November 18 by Goldman Sachs. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) earned “Hold” rating by Cowen & Co on Monday, June 26. The stock has “Hold” rating by Oppenheimer on Wednesday, November 8. See Seattle Genetics, Inc. (NASDAQ:SGEN) latest ratings:

13/11/2017 Broker: RBC Capital Markets Rating: Buy New Target: $69.0 Maintain
08/11/2017 Broker: Oppenheimer Rating: Hold Initiate
27/10/2017 Broker: Piper Jaffray Rating: Hold New Target: $55.0 Maintain
30/10/2017 Broker: JP Morgan Rating: Neutral Old Target: $55 New Target: $60 Maintain
27/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $68.0 Maintain
27/10/2017 Broker: SunTrust Rating: Hold New Target: $52.0 Maintain
27/10/2017 Broker: H.C. Wainwright Rating: Buy New Target: $75.0 Maintain
27/10/2017 Broker: Bank of America Rating: Hold New Target: $70.0 Upgrade
23/10/2017 Broker: Needham Rating: Buy New Target: $72.0 Maintain
23/10/2017 Broker: Guggenheim Rating: Buy New Target: $72.0 Initiate

Jag Capital Management Llc decreased Applied Materials Inc. (AMAT) stake by 37.98% reported in 2017Q2 SEC filing. Jag Capital Management Llc sold 170,468 shares as Applied Materials Inc. (AMAT)’s stock rose 23.58%. The Jag Capital Management Llc holds 278,342 shares with $11.50M value, down from 448,810 last quarter. Applied Materials Inc. now has $54.40 billion valuation. The stock increased 1.86% or $0.93 during the last trading session, reaching $51.01. About 19.30 million shares traded or 71.84% up from the average. Applied Materials, Inc. (NASDAQ:AMAT) has risen 121.40% since December 7, 2016 and is uptrending. It has outperformed by 104.70% the S&P500.

The stock increased 1.25% or $0.7 during the last trading session, reaching $56.75. About 1.03 million shares traded or 5.25% up from the average. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since December 7, 2016 and is uptrending. It has outperformed by 58.98% the S&P500.

Seattle Genetics, Inc., a biotechnology company, develops and commercializes targeted therapies to treat cancer worldwide. The company has market cap of $8.17 billion. It markets ADCETRIS, an antibody-drug conjugate for relapsed Hodgkin lymphoma and relapsed systemic anaplastic large cell lymphoma. It currently has negative earnings. The firm also develops SGN-CD33A that is in Phase III clinical trial to evaluate SGN-CD33A in combination with hypomethylating agents in previously untreated older patients, as well as in Phase 1/2 clinical trial for patients with relapsed or refractory acute myeloid leukemia ; ASG-22ME, which is in Phase I clinical trial for Nectin-4-positive solid tumors, including bladder cancer; SGN-LIV1A that is in Phase 1 clinical trial for patients with LIV-1-positive metastatic breast cancer; and SGN-CD19A, which is in Phase II clinical trial for patients with relapsed DLBCL, as well as in Phase II trial for patients with newly diagnosed DLBCL.

Investors sentiment decreased to 1.3 in Q2 2017. Its down 0.20, from 1.5 in 2017Q1. It fall, as 30 investors sold Seattle Genetics, Inc. shares while 75 reduced holdings. 48 funds opened positions while 89 raised stakes. 137.48 million shares or 0.82% less from 138.62 million shares in 2017Q1 were reported. Moreover, Wells Fargo & Com Mn has 0% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 267,976 shares. Spark Invest Mngmt has invested 0.44% in Seattle Genetics, Inc. (NASDAQ:SGEN). 12,000 were reported by Numeric Limited Liability Company. Moreover, First Quadrant Limited Partnership Ca has 0% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 1,000 shares. 640,000 were accumulated by Tourbillon Cap Limited Partnership. Stevens Cap Limited Partnership reported 66,301 shares stake. Moreover, Sivik Glob Ltd Llc has 0.47% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 25,000 shares. Alliancebernstein Limited Partnership stated it has 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Susquehanna Llp invested 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Pub Employees Retirement Association Of Colorado has 0.01% invested in Seattle Genetics, Inc. (NASDAQ:SGEN). Alpha Windward Limited Liability Corporation has invested 0.01% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Atria Investments Ltd invested 0.02% in Seattle Genetics, Inc. (NASDAQ:SGEN). 362,074 were accumulated by Morgan Stanley. Macquarie Grp Inc Incorporated Limited owns 95,917 shares. Architects Inc invested in 0.01% or 1,271 shares.

Among 28 analysts covering Applied Materials Inc. (NASDAQ:AMAT), 27 have Buy rating, 0 Sell and 1 Hold. Therefore 96% are positive. Applied Materials Inc. had 106 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was downgraded by Citigroup on Friday, October 23 to “Neutral”. Susquehanna downgraded the shares of AMAT in report on Tuesday, April 19 to “Negative” rating. The rating was maintained by UBS on Friday, August 19 with “Buy”. On Thursday, August 6 the stock rating was maintained by Piper Jaffray with “Buy”. Needham upgraded Applied Materials, Inc. (NASDAQ:AMAT) rating on Friday, February 19. Needham has “Buy” rating and $22 target. The firm earned “Neutral” rating on Friday, February 19 by B. Riley & Co. The stock of Applied Materials, Inc. (NASDAQ:AMAT) earned “Hold” rating by RBC Capital Markets on Tuesday, August 1. On Wednesday, November 11 the stock rating was maintained by Cowen & Co with “Outperform”. The firm earned “Buy” rating on Wednesday, November 15 by Bank of America. The stock has “Sector Perform” rating by RBC Capital Markets on Friday, June 10.

Jag Capital Management Llc increased Alphabet Inc Class A stake by 526 shares to 10,427 valued at $9.69M in 2017Q2. It also upped Micron Technology Inc. (NASDAQ:MU) stake by 232,788 shares and now owns 490,974 shares. Illumina Inc (NASDAQ:ILMN) was raised too.

Investors sentiment decreased to 0.82 in 2017 Q2. Its down 0.33, from 1.15 in 2017Q1. It dived, as 48 investors sold AMAT shares while 346 reduced holdings. 105 funds opened positions while 219 raised stakes. 826.54 million shares or 0.80% less from 833.19 million shares in 2017Q1 were reported. State Street Corp reported 0.18% in Applied Materials, Inc. (NASDAQ:AMAT). Moore Capital Lp has invested 0.44% in Applied Materials, Inc. (NASDAQ:AMAT). Chevy Chase stated it has 0.22% of its portfolio in Applied Materials, Inc. (NASDAQ:AMAT). Srb Corp reported 0.02% of its portfolio in Applied Materials, Inc. (NASDAQ:AMAT). Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.18% or 432,663 shares. Cornercap Invest Counsel reported 127,000 shares or 0.88% of all its holdings. Winfield Assocs owns 13,220 shares. Brandywine Invest Management Limited Liability Com reported 962,037 shares. Ledyard Bank & Trust has 0.3% invested in Applied Materials, Inc. (NASDAQ:AMAT) for 51,200 shares. Fmr Ltd Llc reported 30.07M shares. Mitsubishi Ufj Securities Limited accumulated 7,330 shares. Ifrah Inc holds 0.28% or 17,300 shares. Hood River Limited Liability Corp has invested 0% in Applied Materials, Inc. (NASDAQ:AMAT). Moreover, Patten Inc has 0.34% invested in Applied Materials, Inc. (NASDAQ:AMAT). Moreover, Waters Parkerson And Com Lc has 0.03% invested in Applied Materials, Inc. (NASDAQ:AMAT).

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>